Louis Lazar, PhD, joined Newry Corp in 2013 after completing his doctorate in Biochemistry and a postdoctoral fellowship at Brandeis University. His work at Newry has covered technologies ranging from functional fluids to microreplicated materials to display components, and several of his recent projects have focused on next-generation telecommunications equipment for 5G. The outcomes of these engagements have included M&A target identification, competitive intelligence, and a comprehensive portfolio strategy for an R&D directorate at a Fortune 500 company.
Before joining Newry, Louis worked in academic scientific research, focusing on developing novel methods to improve rational drug design techniques. In addition to his doctoral degree, Louis has a BS in Biochemistry and Molecular Biology and Mathematics from Dickinson College.